Lung transplantation in Australia: Barriers to translating new evidence into clinical practice

Medical Journal of Australia

Volumn 184, Issue 9, 2006, Pages 428-429

  Snell, Greg ^a,b   Kotsimbos, Tom ^a,b   Williams, Trevor J ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; EVEROLIMUS; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

AUSTRALIA; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG INDICATION; EDITORIAL; EVIDENCE BASED MEDICINE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG DISEASE; LUNG TRANSPLANTATION; NEPHROTOXICITY; OPPORTUNISTIC INFECTION; PRESCRIPTION; RANDOMIZATION; SURVIVAL;

EID: 33646397304     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2006.tb00311.x     Document Type: Editorial

References (8)

1. Studer SM, Levy RD, McNeil K, Orens JB. Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness. Eur Respir J 2004; 24: 674-685.
2. Iacono AT, Johnson BA, Grgurich WF, et al. A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med 2006; 354: 141-150.
3. Reitz BA, Wallwork JL, Hunt SA, et al. Heart lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med 1982; 306: 557-564.
4. Annual Report of The Australia and New Zealand Organ Donation Registry (ANZOD). The 2005 report. Available at: http://www.anz-data.org.au/ANZOD/ANZODReport/anzodreport.htm#2005 (accessed Mar 2006).
5. Trulock EP, Edwards LB, Taylor DO, et al. The Registry of the International Society for Heart and Lung Transplantation: twentieth official adult lung and heart-lung transplant report - 2005. J Heart Lung Transplant 2005; 24: 956-968.
6. Snell GI, Valentine VG, Vitulo P, et al. Everolimus versus azathioprine as adjunctive therapy to inhibit the lung function decline in stable lung transplant recipients: 12 and 24-month results of an international, randomized, double-blind study. Am J Transplant 2006; 6: 169-177.
7. Corris P, Glanville AR, McNeil KD, et al. One year analysis of an ongoing international randomized study of mycophenolate mofetil (MMF) vs azathioprine (AZA) in lung transplantation. J Heart Lung Transplant 2001; 20: 149-150.
8. DeCamp MM. Inhaled cyclosporine - a breath of fresh air? N Engl J Med 2006; 354: 191-193.